NCT06163040 2025-07-31A Study to Evaluate the Safety of EmplicitiĀ® (Elotuzumab) When Treating Patients With Multiple Myeloma in TaiwanBristol-Myers SquibbCompleted7 enrolled
NCT02555839 2025-03-28Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical PracticeCelgeneCompleted127 enrolled